Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Biological Chemistry
|
November 15, 2000
The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways
X Cortes-Bratti, C Karlsson, T Lagergård, et al.
Nature Cell Biology
|
March 7, 2001
c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells
R Gavioli, T Frisan, S Vertuani, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 22, 1998
The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time
V Levitsky, P O de Campos-Lima, T Frisan, et al.
International Journal of Cancer
|
February 15, 1994
In vivo phenotypic characteristics of AKR T-cell lymphomas with different leukemic potential: possible role of alpha 4 beta 7 integrin in the progression towards the leukemic phenotype
R Dolcetti, T Frisan, G Palmieri, et al.
International Journal of Cancer
|
December 22, 1999
CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines
T Frisan, D Donati, L Cervenak, et al.
International Journal of Cancer
|
October 9, 1996
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells
T Frisan, Q J Zhang, J Levitskaya, et al.
American Journal of Clinical Pathology
|
November 1, 1993
Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineage
R Dolcetti, A Carbone, V Zagonel, et al.
Blood
|
August 15, 1995
Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease
T Frisan, J Sjöberg, R Dolcetti, et al.
Blood
|
January 29, 2000
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells
A Gustafsson, V Levitsky, J Z Zou, et al.
Cancer Research
|
August 15, 1995
Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease
R Dolcetti, T Frisan, J Sjöberg, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Biological Chemistry
|
November 15, 2000
The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways
X Cortes-Bratti, C Karlsson, T Lagergård, et al.
Nature Cell Biology
|
March 7, 2001
c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells
R Gavioli, T Frisan, S Vertuani, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 22, 1998
The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time
V Levitsky, P O de Campos-Lima, T Frisan, et al.
International Journal of Cancer
|
February 15, 1994
In vivo phenotypic characteristics of AKR T-cell lymphomas with different leukemic potential: possible role of alpha 4 beta 7 integrin in the progression towards the leukemic phenotype
R Dolcetti, T Frisan, G Palmieri, et al.
International Journal of Cancer
|
December 22, 1999
CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines
T Frisan, D Donati, L Cervenak, et al.
International Journal of Cancer
|
October 9, 1996
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells
T Frisan, Q J Zhang, J Levitskaya, et al.
American Journal of Clinical Pathology
|
November 1, 1993
Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineage
R Dolcetti, A Carbone, V Zagonel, et al.
Blood
|
August 15, 1995
Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease
T Frisan, J Sjöberg, R Dolcetti, et al.
Blood
|
January 29, 2000
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells
A Gustafsson, V Levitsky, J Z Zou, et al.
Cancer Research
|
August 15, 1995
Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease
R Dolcetti, T Frisan, J Sjöberg, et al.
Page
of 2